文献速递免疫规划卫生政策与健康促进

欧洲疫苗接种现状报告

A report on the status of vaccination in Europe.
PubMed 文献 · Vaccine · 2018-07-04

该报告通过评估16个欧洲国家的国家疫苗接种策略与实施、医疗疫苗接种系统属性以及普遍大规模接种(UMV)的结果,描绘各国疫苗政策、决策过程和结果的差异。婴儿百白破疫苗覆盖率范围为89.1%至98.2%,青少年人乳头瘤病毒疫苗为5%至85.9%,老年人流感疫苗为4.3%至71.6%。报告认为尽管方法、目标和报告系统不同,儿科疫苗接种可实现高覆盖率,但其他年龄组疫苗未能复制这一水平,需要额外措施提高所有年龄组的疫苗接种覆盖率。

要点

  • 16个欧洲国家的婴儿百白破疫苗覆盖率范围为89.1%至98.2%。
  • 青少年人乳头瘤病毒疫苗覆盖率范围为5%至85.9%。
  • 老年人流感疫苗覆盖率范围为4.3%至71.6%。

核心结论

  • 尽管方法、目标和报告系统不同,儿科疫苗接种可实现高覆盖率,但同一国家的其他年龄组疫苗未能复制这一水平。
  • 需要额外措施提高所有年龄组的疫苗接种覆盖率,并可能受益于欧盟国家在目标设定、疫苗接种数据收集和共享方面更大程度的协调统一。

研究设计与样本

  • 该报告通过评估16个欧洲国家的国家疫苗接种策略与实施、医疗疫苗接种系统属性以及普遍大规模接种(UMV)的结果,描绘各国疫苗政策、决策过程和结果的差异。

主要发现

  • 11个国家使用标准化评估框架为疫苗推荐提供依据。
  • 仅瑞典对新技术的地平线扫描、标准评估、系统文献和卫生经济综述以及公布决策理由均有采用。
  • 14个国家计划每年报告国家疫苗覆盖率(VCR),并针对不同年龄组每种疫苗设有目标VCR。
  • 10个国家使用电子免疫记录或集中登记系统记录儿童疫苗接种,7个国家用于其他年龄组疫苗接种。
  • 国家VCR范围:婴儿(初级百白破)含百白破疫苗为89.1%至98.2%,青少年(人乳头瘤病毒)疫苗接种为5%至85.9%,老年人(季节性流感)疫苗接种为4.3%至71.6%。

关键数值与推荐

  • 婴儿(初级百白破)含百白破疫苗国家VCR范围为89.1%至98.2%。
  • 青少年(人乳头瘤病毒)疫苗接种国家VCR范围为5%至85.9%。
  • 老年人(季节性流感)疫苗接种国家VCR范围为4.3%至71.6%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccine policy, decision processes and outcomes vary widely across Europe. The objective was to map these factors across 16 European countries by assessing (A) national vaccination strategy and implementation, (B) attributes of healthcare vaccination systems, and (C) outcomes of universal mass vaccination (UMV) as a measure of how successful the vaccination policy is. A. Eleven countries use standardised assessment frameworks to inform vaccine recommendations. Only Sweden horizon scans new technologies, uses standard assessments, systematic literature and health economic reviews, and publishes its decision rationale. Time from European marketing authorisation to UMV implementation varies despite these standard frameworks. Paediatric UMV recommendations (generally government-funded) are relatively comparable, however only influenza vaccine is widely recommended for adults. B. Fourteen countries aim to report annually on national vaccine coverage rates (VCRs), as well as have target VCRs per vaccine across different age groups. Ten countries use either electronic immunisation records or a centralised registry for childhood vaccinations, and seven for other age group vaccinations. C. National VCRs for infant (primary diphtheria tetanus pertussis (DTP)), adolescent (human papillomavirus (HPV)) and older adult (seasonal influenza) UMV programmes found ranges of: 89.1% to 98.2% for DTP-containing vaccines, 5% to 85.9% for HPV vaccination, and 4.3% to 71.6% for influenza vaccine. Regarding reported disease incidence, a wide range was found across countries for measles, mumps and rubella (in children), and hepatitis B and invasive pneumococcal disease (in all ages). These findings reflect an individual approach to vaccination by country. High VCRs can be achieved, particularly for paediatric vaccinations, despite different approaches, targets and reporting systems; these are not replicated in vaccines for other age groups in the same country. Additional measures to improve VCRs across all age groups are needed and could benefit from greater harmonisation in target setting, vaccination data collection and sharing across EU countries.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sheikh S, Biundo E, Courcier S, et al. A report on the status of vaccination in Europe. Vaccine. 2018. PMID: 30037416. doi:10.1016/j.vaccine.2018.06.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。